skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,925  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Diabetes remove subject: Male remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2016-03, Vol.374 (11), p.1092-1094 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1600827 ;PMID: 26981940

Full text available

2
International trends in hepatocellular carcinoma incidence, 1978-2012
Material Type:
Article
Add to My Research

International trends in hepatocellular carcinoma incidence, 1978-2012

International journal of cancer, 2020-07, Vol.147 (2), p.317 [Peer Reviewed Journal]

Published 2019. This article is a U.S. Government work and is in the public domain in the USA. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32723 ;PMID: 31597196

Digital Resources/Online E-Resources

3
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Material Type:
Article
Add to My Research

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

The New England journal of medicine, 2019-11, Vol.381 (21), p.2032-2042 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1908419 ;PMID: 31556978

Full text available

4
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis
Material Type:
Article
Add to My Research

Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis

European journal of epidemiology, 2018-09, Vol.33 (9), p.811-829 [Peer Reviewed Journal]

Springer Nature B.V. 2018 ;The Author(s) 2018 ;European Journal of Epidemiology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0393-2990 ;EISSN: 1573-7284 ;DOI: 10.1007/s10654-018-0380-1 ;PMID: 29589226

Full text available

5
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Material Type:
Article
Add to My Research

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

The New England journal of medicine, 2019-01, Vol.380 (1), p.23-32 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1811403 ;PMID: 30415637

Full text available

6
Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States
Material Type:
Article
Add to My Research

Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States

JAMA : the journal of the American Medical Association, 2017-03, Vol.317 (9), p.912 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2017.0947 ;PMID: 28267855

Digital Resources/Online E-Resources

7
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2016-11, Vol.375 (19), p.1834-1844 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607141 ;PMID: 27633186

Full text available

8
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31149-3 ;PMID: 31189511

Full text available

9
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Material Type:
Article
Add to My Research

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

The New England journal of medicine, 2016-12, Vol.375 (22), p.2144-2153 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1604304 ;PMID: 27959767

Full text available

10
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

The New England journal of medicine, 2016-07, Vol.375 (4), p.323-334 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1515920 ;PMID: 27299675

Full text available

11
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Material Type:
Article
Add to My Research

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetes care, 2020-02, Vol.43 (2), p.487-493 [Peer Reviewed Journal]

2019 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2020 ;2019 by the American Diabetes Association. 2019 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci19-0066 ;PMID: 31857443

Full text available

12
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Material Type:
Article
Add to My Research

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

Diabetes care, 2020-07, Vol.43 (7), p.1399-1407 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0660 ;PMID: 32409498

Full text available

13
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Material Type:
Article
Add to My Research

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

The New England journal of medicine, 2020-04, Vol.382 (16), p.1507-1519 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1912387 ;PMID: 32187462

Full text available

14
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
Material Type:
Article
Add to My Research

Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study

BMJ (Online), 2020-01, Vol.368, p.l6669-l6669 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6669 ;PMID: 31915124

Full text available

15
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Material Type:
Article
Add to My Research

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (7), p.644-657 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611925 ;PMID: 28605608

Full text available

16
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32261-X ;PMID: 30291013

Full text available

17
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Material Type:
Article
Add to My Research

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

The New England journal of medicine, 2019-02, Vol.380 (8), p.752-762 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Copyright © 2018 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809798 ;PMID: 30415610

Full text available

18
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2018-08, Vol.379 (7), p.633-644 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1800256 ;PMID: 30110583

Full text available

19
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237

Full text available

20
High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies
Material Type:
Article
Add to My Research

High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies

Diabetic medicine, 2017-09, Vol.34 (9), p.1185 [Peer Reviewed Journal]

2017 Diabetes UK. ;EISSN: 1464-5491 ;DOI: 10.1111/dme.13403 ;PMID: 28722225

Digital Resources/Online E-Resources

Results 1 - 20 of 4,925  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1993  (12)
  2. 1993 To 2000  (64)
  3. 2001 To 2008  (445)
  4. 2009 To 2017  (2,559)
  5. After 2017  (1,846)
  6. More options open sub menu

Resource Type 

  1. Articles  (4,923)
  2. magazinearticle  (2)
  3. More options open sub menu

Subject 

  1. Humans  (4,912)
  2. Science & Technology  (4,709)
  3. Female  (4,633)
  4. Middle Aged  (3,751)
  5. Life Sciences & Biomedicine  (3,659)
  6. Risk Factors  (3,339)
  7. Aged  (2,942)
  8. Adult  (2,607)
  9. Cardiovascular Disease  (2,172)
  10. Diabetes Mellitus  (1,910)
  11. Mortality  (1,568)
  12. Hypertension  (1,522)
  13. Studies  (1,418)
  14. Body Mass Index  (1,227)
  15. Cardiovascular Diseases  (1,190)
  16. Health Risks  (1,102)
  17. Population  (1,097)
  18. More options open sub menu

Language 

  1. Japanese  (684)
  2. Portuguese  (11)
  3. Norwegian  (8)
  4. French  (4)
  5. German  (2)
  6. Persian  (1)
  7. Italian  (1)
  8. Chinese  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait